“WHO is encouraged by the fact that more than 30 candidate vaccines are currently undergoing various stages of clinical trials, including in the Russia,” Vujnovic said.
According to her, the WHO continues to interact with Russian scientists and authorities and is looking forward to learning the details of the Russian vaccine trials.
On Aug. 11, Russia became the first country in the world to register a vaccine against the coronavirus, named Sputnik V and developed by the Gamaleya Research Institute of Epidemiology and Microbiology.
The vaccine is currently undergoing phase 3 of clinical trials.
